Inventor · disambiguated record
Jode Goodridge
Also filed as: GOODRIDGE JODE
5 granted patents·11 pending applications·31 citations·filing 2018–2025
76Inventor score
Files withFATE THERAPEUTICS INC16
Top patents by PatentIndex Score
16 records- 0197US11365394B2Enhanced immune effector cells and use thereofFATE THERAPEUTICS INC·Filed 2021·Granted Jun 21, 2022·14 cites·20 claims
- 0296US10927346B2Enhanced immune effector cells and use thereofFATE THERAPEUTICS INC·Filed 2019·Granted Feb 23, 2021·17 cites·22 claims
- 0375US12173274B2Enhanced immune effector cells and use thereofFATE THERAPEUTICS INC·Filed 2021·Granted Dec 24, 2024·0 cites·22 claims
- 0473US12398373B2Enhanced immune effector cells and use thereofFATE THERAPEUTICS INC·Filed 2018·Granted Aug 26, 2025·0 cites·26 claims
- 0573US2025145966A1Enhanced immune effector cells and use thereofFATE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0669US12275955B2Combining iPSC derived effector cell types for immunotherapy useFATE THERAPEUTICS INC·Filed 2021·Granted Apr 15, 2025·0 cites·40 claims
- 0766US2025339532A1Stealth strategy engaging immune recognition pathways for use in allogeneic cell therapiesFATE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0863US2025313802A1Combining ipsc derived effector cell types for immunotherapy useFATE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0961US2021163622A1Immune effector cell engineering and use thereofFATE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1059US2022275333A1Immune effector cell engineering and use thereofFATE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1157US2024307540A1Protected effector cells and use thereof for allogeneic adoptive cell therapiesFATE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1253US2023016034A1ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDSFATE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1352US2024115602A1Enhanced chimeric antigen receptor for immune effector cell engineering and use thereofFATE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1452US2024226293A9Enhanced chimeric antigen receptor for immune effector cell engineering and use thereofFATE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1552US2022378831A1Multi-targeting effector cells and use thereofFATE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1648US2021024959A1Engineered immune effector cells and use thereofFATE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jode Goodridge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →